Search

Displaying results 2411 - 2420 of 10000 in total
  1. Drug

    GLB-005

    go.drugbank.com/drugs/DB32797
    Experimental

    GLB-005 is a molecular glue degrader targeting WIZ and is being investigated for treatment of sickle cell disease and β-thalassemia.[L56125, L56126, L56128]

  2. Drug

    GLB-007

    go.drugbank.com/drugs/DB32798
    Experimental

    GLB-007 is a molecular glue degrader targeting WIZ and ZBTB7A.[L56125, L56126, L56128]

  3. Drug

    GLB-006

    go.drugbank.com/drugs/DB32799
    Experimental

    GLB-006 is a molecular glue degrader targeting NEK7.[L56125, L56126]

  4. Drug

    APT20TTMG

    go.drugbank.com/drugs/DB32869
    Experimental

    APT20TTMG is a synthetic DNA that modulates U1 small nuclear ribonucleoprotein misassembly.

  5. Drug

    RS5441

    go.drugbank.com/drugs/DB33178
    Experimental

    RS5441, also known as ET-02, is a small molecule topical medication investigated for male pattern baldness and age-related alopecia.[L57508, L57509]

  6. Drug

    Gadoquatrane

    go.drugbank.com/drugs/DB33282
    Approved

    Gadoquatrane is a macrocyclic gadolinium-based contrast agent used to enhance magnetic resonance imaging. … [L63814] Like other gadolinium agents it is paramagnetic, developing a magnetic moment in the scanner's field that alters the relaxation of nearby water protons and brightens tissues with abnormal vascularity

  7. Drug

    Enlimomab

    go.drugbank.com/drugs/DB33731
    Experimental

    Categories: Intercellular Adhesion Molecule-1
  8. Drug

    Amniotic membrane

    go.drugbank.com/drugs/DB33970
    Experimental

    Amniotic membrane is a biologic drug.

  9. Drug

    MGC030

    go.drugbank.com/drugs/DB33973
    Experimental

    MGC030 is a biologic drug. MGC030 is under investigation in clinical trial NCT07822399 (A Study of MGC030 in Participants With Advanced Solid Tumors).

  10. Drug

    VH5356136

    go.drugbank.com/drugs/DB33975
    Experimental

    VH5356136 is a small molecule drug. … VH5356136 is under investigation in clinical trial NCT07822477 (A Study to Investigate Safety, Tolerability and Pharmacokinetics of VH5356136 in Adult Participants Without HIV).